BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 869901)

  • 21. Increased urinary excretion of argininosuccinate in type II citrullinemia.
    Saheki T; Kobayashi K; Inoue I; Matuo S; Hagihara S; Noda T
    Clin Chim Acta; 1987 Dec; 170(2-3):297-304. PubMed ID: 3436063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrullinemia: prenatal diagnosis of an affected fetus.
    Fleisher LD; Harris CJ; Mitchell DA; Nadler HL
    Am J Hum Genet; 1983 Jan; 35(1):85-90. PubMed ID: 6823975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementation in argininosuccinate synthetase and argininosuccinate lyase deficiencies in human fibroblasts.
    Cathelineau L; Pham Dinh D; Briand P; Kamoun P
    Adv Exp Med Biol; 1982; 153():101-10. PubMed ID: 7164890
    [No Abstract]   [Full Text] [Related]  

  • 24. Retroviral-mediated gene therapy for the treatment of citrullinemia. Transfer and expression of argininosuccinate synthetase in human hematopoietic cells.
    Demarquoy J
    Experientia; 1993 Apr; 49(4):345-8. PubMed ID: 8477837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Messenger RNA coding for argininosuccinate synthetase in citrullinemia.
    Kobayashi K; Saheki T; Imamura Y; Noda T; Inoue I; Matuo S; Hagihara S; Nomiyama H; Jinno Y; Shimada K
    Am J Hum Genet; 1986 May; 38(5):667-80. PubMed ID: 3459354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heterogeneous distribution of argininosuccinate synthetase in the liver of type II citrullinemic patients. Its specificity and possible clinical implications.
    Yagi Y; Saheki T; Imamura Y; Kobayashi K; Sase M; Nakano K; Matuo S; Inoue I; Hagihara S; Noda T
    Am J Clin Pathol; 1988 Jun; 89(6):735-41. PubMed ID: 3369364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymatic analysis of citrullinemia (12 cases) in Japan.
    Saheki T; Ueda A; Hosoya M; Sase M; Nakano K; Katsunuma T
    Adv Exp Med Biol; 1982; 153():63-76. PubMed ID: 7164923
    [No Abstract]   [Full Text] [Related]  

  • 28. An adult-onset case of argininosuccinate synthetase deficiency presenting with atypical citrullinemia.
    Osafune K; Ichikawa K; Yasui T; Sekikawa A; Takeoka H; Kanatsu K; Kohigashi K; Koshiyama H
    Intern Med; 1999 Jul; 38(7):590-6. PubMed ID: 10435367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of a mouse model for citrullinemia by targeted disruption of the argininosuccinate synthetase gene.
    Patejunas G; Bradley A; Beaudet AL; O'Brien WE
    Somat Cell Mol Genet; 1994 Jan; 20(1):55-60. PubMed ID: 8197477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additional mutations in argininosuccinate synthetase causing citrullinemia.
    Kobayashi K; Rosenbloom C; Beaudet AL; O'Brien WE
    Mol Biol Med; 1991 Feb; 8(1):95-100. PubMed ID: 1943692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal diagnosis of citrullinemia: elevated levels of citrulline in the amniotic fluid in the three affected pregnancies.
    Kleijer WJ; Blom W; Huijmans JG; Mooyman MC; Berger R; Niermeijer MF
    Prenat Diagn; 1984; 4(2):113-8. PubMed ID: 6739433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosynthesis of urea. Molecular and regulatory properties of crystalline argininosuccinate synthetase.
    Rochovansky O; Kodowaki H; Ratner S
    J Biol Chem; 1977 Aug; 252(15):5287-94. PubMed ID: 885853
    [No Abstract]   [Full Text] [Related]  

  • 33. Periodic hyperammonemia, hyperlysinemia, and homocitrullinuria associated with decreased argininosuccinate synthetase and arginase activities.
    Sogawa H; Oyanagi K; Nakao T
    Pediatr Res; 1977 Sep; 11(9 Pt 1):949-53. PubMed ID: 904980
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular analysis of argininosuccinate synthetase deficiency in human fibroblasts.
    Su TS; Bock HG; Beaudet AL; O'Brien WE
    J Clin Invest; 1982 Dec; 70(6):1334-9. PubMed ID: 7174798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular definition of bovine argininosuccinate synthetase deficiency.
    Dennis JA; Healy PJ; Beaudet AL; O'Brien WE
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7947-51. PubMed ID: 2813370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic mechanism of argininosuccinate synthetase.
    Raushel FM; Seiglie JL
    Arch Biochem Biophys; 1983 Sep; 225(2):979-85. PubMed ID: 6605113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exclusion of citrullinaemia in the first trimester of pregnancy by direct assay of argininosuccinate synthetase in chorionic villi.
    Christensen E; Brandt NJ; Philip J; Bang J
    Prenat Diagn; 1985; 5(4):299-301. PubMed ID: 4048069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic cell genetic evidence for the presence of a gene for citrullinemia on human chromosome 9.
    Carritt B
    Cytogenet Cell Genet; 1977; 19(1):44-8. PubMed ID: 891260
    [No Abstract]   [Full Text] [Related]  

  • 39. Measurement of positional isotope exchange rates in enzyme-catalyzed reactions by fast atom bombardment mass spectrometry: application to argininosuccinate synthetase.
    Hilscher LW; Hanson CD; Russell DH; Raushel FM
    Biochemistry; 1985 Oct; 24(21):5888-93. PubMed ID: 2867775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic mutations in argininosuccinate synthetase deficiency: characterisation and in vitro correction by substrate supplementation.
    Diez-Fernandez C; Wellauer O; Gemperle C; Rüfenacht V; Fingerhut R; Häberle J
    J Med Genet; 2016 Oct; 53(10):710-9. PubMed ID: 27287393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.